Patents by Inventor Richard Meagher

Richard Meagher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10437345
    Abstract: A sensor system includes a finger mount comprising a sleeve, where the sleeve is configured to attach to a finger of a user. The system also includes a processing unit coupled to the finger mount, and a sensory attachment coupled to the finger mount, where the sensory attachment is communicatively coupled to the processing unit. The system also includes a grounding component conductively coupled to the finger mount.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: October 8, 2019
    Assignee: The Boeing Company
    Inventors: Richard Meagher, John W. Glatfelter
  • Publication number: 20190004610
    Abstract: A sensor system includes a finger mount comprising a sleeve, where the sleeve is configured to attach to a finger of a user. The system also includes a processing unit coupled to the finger mount, and a sensory attachment coupled to the finger mount, where the sensory attachment is communicatively coupled to the processing unit. The system also includes a grounding component conductively coupled to the finger mount.
    Type: Application
    Filed: June 30, 2017
    Publication date: January 3, 2019
    Inventors: Richard Meagher, John W. Glatfelter
  • Publication number: 20070207539
    Abstract: The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.
    Type: Application
    Filed: November 16, 2006
    Publication date: September 6, 2007
    Inventors: Richard Meagher, Vince Laterza
  • Publication number: 20070101459
    Abstract: The present disclosure provides methods, recombinant DNA molecules, recombinant host cells containing the DNA molecules, and transgenic plant cells, plant tissue and plants which contain and express at least one antisense or interference RNA specific for a thiamine biosynthetic coding sequence or a thiamine binding protein, wherein the RNA or thiamine binding protein is expressed under the regulatory control of a transcription regulatory sequence which directs expression in reproductive tissue. These transgenic plants are conditionally sterile; i.e., they are fertile only in the presence of exogenous thiamine. Such plants are especially appropriate for use in the seed industry or in the environment, for example, for use in revegetation of contaminated soils or phytoremediation, especially when those transgenic plants also contain and express one or more chimeric genes which confer resistance to contaminants.
    Type: Application
    Filed: June 3, 2004
    Publication date: May 3, 2007
    Inventors: Richard Meagher, Elizabeth McKinney, Tehryung Kim
  • Publication number: 20050216976
    Abstract: Plant tissue specific gene expression by way of repressor-operator complexes, has enabled outcomes including, without limitation, male sterility and engineered plants having root-specific gene expression of relevant proteins to clean environmental pollutants from soil and water. A mercury hyperaccumulation strategy requires that mercuric ion reductase coding sequence is strongly expressed. The actin promoter vector, A2pot, engineered to contain bacterial lac operator sequences, directed strong expression in all plant vegetative organs and tissues. In contrast, the expression from the A2pot construct was restricted primarily to root tissues when a modified bacterial repressor (Lacln) was coexpressed from the light-regulated rubisco small subunit promoter in above-ground tissues. Also provided are analogous repressor operator complexes for selective expression in other plant tissues, for example, to produce male sterile plants.
    Type: Application
    Filed: January 18, 2005
    Publication date: September 29, 2005
    Inventors: Richard Meagher, Rebecca Balish, Kim Tehryung, Elizabeth McKinney
  • Publication number: 20050198707
    Abstract: The present disclosure provides methods, recombinant DNA molecules, recombinant host cells containing the DNA molecules, and transgenic plant cells, plant tissue and plants which contain and express at least one phytochelatin biosynthetic coding sequence under the regulatory control of the strong ACT2 constitutive promoter or the light-inducible SRS1 promoter and/or a plant-expressible arsenate reductase coding sequence. Optionally the plant expressing the at least one phytochelatin biosynthetic enzyme coding sequence can also express a mercuric ion reductase coding sequence. The transgenic plants are tolerant of heavy metal ions, e.g., cadmium, arsenate and/or mercury, and can accumulate those ions from a contaminated environment, to thus, effect phytoremediation of a contaminated soil or water environment which contains mercury, cadmium and/or arsenate ions.
    Type: Application
    Filed: December 13, 2001
    Publication date: September 8, 2005
    Inventors: Richard Meagher, Yujing Li, Om Dhankher